International demand for Moderna's COVID-19 vaccines is stabilizing.

Statements (2)

1. ▲ Bullish

   Moderna's revenue jumped 29% on international COVID vaccine sales.

   nasdaq.comNov 6, 2026 16:58 UTCHigh importance
2. ● Neutral

   International demand for Moderna's COVID-19 vaccines is stabilizing.

   valor.globo.comNov 6, 2026 16:18 UTC